Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.35 in the prior trading day, TransCode Therapeutics Inc (NASDAQ: RNAZ) closed at $0.38, up 8.00%. In other words, the price has increased by $8.00 from its previous closing price. On the day, 4.58 million shares were traded. RNAZ stock price reached its highest trading level at $0.4394 during the session, while it also had its lowest trading level at $0.355.
Ratios:
Our goal is to gain a better understanding of RNAZ by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 28 ’23 when Fitzgerald Thomas A bought 49,350 shares for $0.51 per share. The transaction valued at 25,168 led to the insider holds 56,318 shares of the business.
Dudley Robert Michael bought 98,000 shares of RNAZ for $49,980 on Sep 28 ’23. The Chief Executive Officer now owns 180,262 shares after completing the transaction at $0.51 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNAZ now has a Market Capitalization of 6526434 and an Enterprise Value of 3399113.
Stock Price History:
Over the past 52 weeks, RNAZ has reached a high of $128.00, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -0.66%, while the 200-Day Moving Average is calculated to be -76.76%.
Shares Statistics:
The stock has traded on average 1.33M shares per day over the past 3-months and 1875170 shares per day over the last 10 days, according to various share statistics. A total of 17.27M shares are outstanding, with a floating share count of 17.23M. Insiders hold about 0.19% of the company’s shares, while institutions hold 11.46% stake in the company. Shares short for RNAZ as of 1724976000 were 278561 with a Short Ratio of 0.21, compared to 1722384000 on 1635985. Therefore, it implies a Short% of Shares Outstanding of 278561 and a Short% of Float of 1.6099999999999999.
